Skip to main content

Advertisement

Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate

Fig. 4

In the upper part of figure the Kaplan survival curve free from atrial fibrillation (AF) events. In lower part the study endpoints events at 12th month of follow up in overall population, patients with diabetes GLP-1 agonist users vs. never GLP-1 agonist users. *p value < 0.05 for both images. AF: atrial fibrillation; CRTd: cardiac resynchronization with a defibrillator; VT: ventricular tachycardia

Back to article page